Richard D. Klausner

Richard Daniel Klausner is an American scientist who served as the 11th director of the National Cancer Institute of the United States.

Early life and education Klausner was born in . Klausner received his MD from Duke Medical School in 1976.

Career In 1979, Klausner joined the National Institutes of Health (NIH) as a postdoctoral fellow. At age 30, Klausner was appointed to the chief of the cell biology and metabolism branch of the National Institute of Child Health and Human Development.

He was the managing partner of the biotech venture capital firm, the Column Group.

He was a member of the Searle Scholars advisory board. He was a scientific advisor at the Fred Hutchinson Cancer Research Center. He has been an Advisor to the Presidents of the Academies for counter-terrorism and a liaison to the White House Office of Science & Technology Policy, and was the chief strategy advisor for USAID.

Klausner co-founded Juno Therapeutics in 2013, GRAIL in 2015.

In 2022, Klausner co-founded Altos Labs and is currently Chief Scientist and Board Co-Chairman of the company.

He was president of the American Society for Clinical Investigation from 1995 to 1996.

Research His research focused on T cells and the potential for CAR-T therapies. He also has published research on the genetics of Von Hippel–Lindau disease, a condition which predisposes a person to developing cancer. 1993 Elected to the National Academy of Sciences 1995 Elected to the American Academy of Arts and Sciences 1997 Dickson Prize in Medicine, University of Pittsburgh 1998 Raymond Bourgine Award for Excellence in Cancer Research and Gold Medal of Paris 1999 ASCI Stanley J. Korsmeyer Award 2000 Medal of Honour, International Agency for Research on Cancer 2018 Elected fellow of the American Association for Cancer Research